Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales ...
As Uganda rolls out mandatory nationwide screening of newborns for sickle cell disease this month, a gene therapy celebrated in the United States and Europe remains financially out of reach for most ...
The Supreme Court seeks information on the cost and availability of Nucleic Acid Amplification Testing (NAT) in government hospitals to detect HIV, hepatitis, and other transfusion transmissible infec ...
Researchers from Brown University and the University of Rochester will lead a multi-institution project to test whether ...
A new study has overcome a long-standing challenge-how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease ...
One-third of children with HIV who received very early ART had no detectable virus in their body for at least 12 weeks after stopping treatment, according to study findings. It was another sign that ...
GLP-1 receptor agonists improve glycemic control and weight while reducing cardiovascular events, with tolerability limited by gastrointestinal adverse effects requiring gradual dose escalation.
A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease ...
By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic ...
Victor Appay, PhD, explains how long-term ART slows immune aging, boosting HIV viral suppression and paving the way for ...
According to one analyst, the alliance and early data “validate” the oncology work of Vir, which was once purely an ...
A recent study confirms lenacapavir's effectiveness against HIV and highlights the capsid as a promising drug target despite resistance.